Investing in Ireland: Issue 61

Happy New Year and welcome to the latest edition of PwC’s newsletter on foreign direct investment (“FDI”) in Ireland.

The resilience of the FDI sector in Ireland is reflected once again in the significant Irish jobs and investments announced over the last quarter of 2024 and the start of 2025 (see page 2).

IDA Ireland, the agency responsible for attracting and retaining foreign direct investment in Ireland, has recently announced its annual results for 2024. In this edition we detail the key results for 2024 and how Ireland is positioned for 2025 and beyond (see page 5).

The pharmaceutical industry is constantly growing and ever-changing. We highlight Ireland's leadership in biopharma manufacturing and cell & gene therapy innovation due to Ireland’s strong ecosystem, significant investments and contributions to global healthcare advancements (see page 6).

Finally, we highlight some recent PwC publications and podcasts on topical issues in the FDI space (see page 8) and summarize Ireland’s strong ranking in a number of key areas for FDI investors (see page 10).

Please do not hesitate to contact myself, any member of our team, or your usual PwC Ireland contact at any stage. We would be happy to tell you more about the topics raised in this issue or to include any interested parties on our mailing list.